Search

Issue
Title
Authors
Personalized approach to systemic treatment of bladder cancer: molecular and genetic markers and new therapeutic strategies (literature review)
Lyubchenko L.N., Ghazaryan K.A., Chernavina K.M., Zaborskiy I.N., Kаryakin O.B., Kaprin A.D.
Long-term oncological outcomes of radical cystectomy with neoadjuvant polychemotherapy in patients with muscle-invasive bladder cancer
Atduev V.A., Ledyaev D.S., Lyubarskaya Y.O., Prikhod’ko N.V., Atduev K.A., Kushaev Z.K., Lipatov D.K.
Bladder cancer: what’s new in 2017—2018
Karyakin O.V., Ivanov S.A., Kaprin A.D.
Clinical case of urachal carcinoma treatment
Nurgaliyev N.S., Ukolova E.A., Satbaeva E.B., Aydarkulov A.A., Rakhimov G.T.
Adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex versus BCG therapy in patients with high risk nonmuscle-invasive bladder cancer
Zamyatin A.V., Mager V.O., Orlov A.S., Il'in K.A., Zavatskiy S.E., Kovalenko D.A., Shcheglova V.P., Berzin S.A., Zyryanov A.V.
Study of association between molecular marker expression on tumor and immunocompetent cells and sensitivity to adjuvant and neoadjuvant therapy of bladder cancer
Zaborskiy I.N., Ivanov S.A., Mushkarina T.Y., Karyakin O.B., Kuzmina E.G., Safiullin K.N., Chaykov V.S., Troyanov A.V., Dementiev I.O., Kasymov M.R., Demyashkin G.A.
Report of a participant of the XI Congress of the Russian Аssociation of Оncological Urology. Bladder cancer: what’s new in 2016
Karyakin O.B.
Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy
Rudakova A.V., Meshkov D.O., Mishugin S.V.
PERI-OPERATIVE CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER: OVERVIEW AND A RATIONALE FOR THE NEED TO SEEK ALTERNATIVE TREATMENT: MAGNOLIA CLINICAL TRIAL
Korneyev I.A., Aboyan I.A., Alekseev B.Y., Apolikhin O.I., Komyakov B.K., Matveev V.B., Colombel M., Heidenreich A., Martínez-Piñeiro L., Babjuk M., Surcel C., Yakovlev P., Colombo R., Radziszewski P., Witjes F., Mulders P., Schipper R., Witjes W.
Biomarkers determining treatment tactics in metastatic urothelial cancer
Grivtsova L.Y., Karyakin O.B., Syadrin M.G., Samborsky S.M., Ivanov S.A., Kaprin A.D.
Evaluation of the efficacy and safety of cabazitaxel in combination with prednisone in patients with metastatic castration-resistant prostate cancer who have previously received docetaxel chemotherapy in daily clinical practice. Results of a Russian multicenter prospective study
Alekseev B.Y., Shevchuk I.M.
Second line chemotherapy in patients with castration-refractory prostate cancer. Ftom clinical studies to practice
Alekseev B.Y., Nyushko K.M., Kaprin A.D.
Somatostatin analogs in the treatment of castrate-resistant prostate cancer: efficacy and tolerability
Kolesnikov G.P., Semkov A.S., Bystrov A.A., Naumova I.N.
RUSSIAN EXPERIENCE WITH TAXOTERE USED IN THERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: RESULTS OF THE DESCRIPTIVE TANDEM STUDYA
Karyakin O.B., Alekseyev B.Y., Matveev V.B., Vorobyev A.V., Nosov A.K., Shevchenko A.N., Burdayeva O.N., Polyakova N.A.
BRAIN METASTASES OF GERM CELL TUMORS. THE RUSSIAN CANCER RESEARCH CENTER'S EXPERIENCE
Tryakin A.A., Fedyanin M.Y., Bulanov A.A., Bekyashev A.K., Aleshin V.A., Mikhina Z.P., Matveev V.B., Zakharova T.I., Garin A.M., Tyulyandin S.A.
Neoadjuvant chemotherapy and radical cystectomy in patients with bladder cancer
Karyakin O.B., Vorobyov N.V., Zaborskiy I.N., Muradyan A.G., Safiullin K.N., Taraki I.A., Demyashkin G.A., Ivanov S.A., Kaprin A.D.
Late complications of the treatment of patients with germ cell tumors
Danielyan D.G., Salimova A.A., Bulanov A.A., Fedyanin M.Y., Tryakin A.A.
The efficacy and safety of vinflunine in second-line therapy of patients with disseminated transitional cell carcinoma of the urinary tract in clinical practice
Volkova M.I., Chernyaev V.A., Matveev V.B., Alekseev B.Y., Nyushko K.M., Bolotina L.V., Kornietskaya A.L., Paichadze A.A., Maikoparova S.C., Ryadinskaya L.A., Kabanov S.N., Storozhakova A.E., Samaneva N.Y., Shcherbinin A.V., Varlamov S.A., Varlamov I.S., Kopyltsov E.I., Lebedinets A.A., Odintsova M.V., Kolesnikov S.S., Karabina E.V.
THE RECURRENCE AFTER ORGAN-SAVING SURGERY OF PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
Sveklina T.A., Krupin V.N.
CURRENT APPROACHES TO TREATING HORMONE REFRACTORY PROSTATE CANCER
Karyakin O.B.
Ewing’s sarcoma of the ureter: a case report
Yurmazov Z.A., Lushnikova N.A., Usynin E.A., Bezgodova N.V., Grigoriev E.G.
Pathologic response to neoadjuvant therapy of high risk prostate cancer
Berkut M.V., Artemjeva A.S., Tolmachev S.S., Reva S.A., Petrov S.V., Nosov A.K.
Long-term results of adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex in patients with high risk nonmuscle-invasive bladder cancer
Zamyatin A.V., Mager V.O., Orlov A.S., Ilyin K.A., Zavatskiy S.E., Kovalenko D.A., Shcheglova V.P., Berzin S.A., Zyryanov A.V.
Hormonal therapy and chemotherapy in patients with hormone-sensitive prostate cancer
Gafanov R.A.
TREATMENT IN PATIENTS WITH MUSCLE NONINVASIVE CARCINOMA OF THE URINARY BLADDER AFTER UNSUCCESSFUL INTRAVESICULAR BCG THERAPY
Figurin K.M.
PREDICTORS OF OVERALL SURVIVAL IN PATIENTS WITH RECURRENT NON-SEMINOMATOUS GERMINAL TESTICULAR TUMORS ON CURRENT SECOND-LINE CHEMOTHERAPY
Fedyanin M.Y., Tryakin A.A., Bulanov A.A., Zakharova T.I., Fanshtein I.A., Figurin K.M., Sergeyev Y.S., Garin A.M., Tyulyandin S.A.
Guideline on trimodal therapy of bladder cancer (Nevskiy consensus 2021)
Novikov R.V., Novikov S.N., Novikov A.I., Petrov S.B., Protsenko S.A., Protoshchak V.V., Popov S.V., Shkolnik M.I., Shpilenya E.S., Kurenkov A.V., Sokurenko V.P., Orlova R.V., Nosov А.K., Korol V.D., Latipova D.K., Mikheeva Y.V., Kanaev S.V.
Bladder cancer: what’s new in 2018–2019
Karyakin О.В.
Small-cell bladder cancer: literature review
Tsedenova K.O., Komarov M.I., Panakhov A.D., Matveev V.B., Sergeev D.A., Beshtoev A.A.
Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem
Alekseev B.Y.
NEW TRENDS IN THE USE OF TAXOTERE (DOCETAXEL) IN PROSTATE CANCER
Karyakin O.B., Biryukov V.A.
ROLE OF ADJUVANT INTRAVESICAL CHEMOTHERAPY IN THE COMBINED ORGAN-SPARING TREATMENT OF NON-MUSCLE-INVASIVE BLADDER CANCER
Zubko A.Y., Nuriev I.R., Sitdykov E.N.
Aspects of hypogonadism in oncological patients receiving antitumor treatment. Literature review
Abramov M.E., Israelyan E.R., Tsareva A.S., Rumyantsev A.A., Firsov K.A., Matveev V.B.
Survival of patients with metastatic bladder cancer in the Russian Federation: results of a multicenter registry study URRU
Tsimafeyeu I.V., Alekseeva G.N., Petkau V.V., Zukov R.A., Mazhbich M.S., Semenov A.V., Statsenko G.B., Novikova O.Y., Zaytsev I.V., Popova I.L., Gurina L.I., Mukhina M.A., Vladimirova L.Y.
Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer
Berkut M.V., Artemjeva A.S., Reva S.A., Tolmachev S.S., Petrov S.B., Nosov A.K.
Current approaches to selection of the 1st line therapy in patients with metastatic hormone-sensitive prostate cancer
Alekseev B.Y., Andrianov A.N., Kaprin A.D.
Experience with octreotide depot in the treatment of castration-resistant prostate cancer
Kolesnikov G.P.
INTRAVESICAL THERAPY FOR BLADDER CANCER: STATE-OF-THE ART
Protoshchak V.V., Kukushkin A.V., Babkin P.A., Shestayev A.Y., Kubin N.D., Shpilenya E.S., Novikov A.I.
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
Burova E.A., Bulanov A.A., Tryakin A.A., Fedyanin M.Y., Matveev V.B., Tulandin S.A.
Therapy with a protein-peptide complex from embryonic stem cells as a method of reducing nephrotoxic effect of chemotherapy drug cisplatin
Kirpatovskiy V.I., Sivkov A.V., Nazirov M.R., Efremov G.D., Sokolov M.A., Komarova Z.V., Frolova E.V., Apolikhin O.I., Kaprin A.D.
Bladder cancer: what’s new in 2019—2020
Karyakin O.B.
The National Registry of treatment regimens in patients with metastatic castration-resistant prostate cancer in the Russian Federation
Karyakin O.B., Kaprin A.D., Ivanov S.A.
Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases
Matveev V.B., Markova A.S.
Cost-effectiveness and budget impact analysis of vinflunine used in the treatment of patients with urothelial transitional cell carcinoma resistant to platinum-based regimens
Kulikov A.Y., Rybchenko Y.V.
CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
Rusakov I.G., Golovashenko M.P.
RETROPERITONEAL LYMPH NODE DISSECTION AFTER INDUCTION CHEMOTHERAPY IN METASTATIC TESTICULAR NON-SEMINOMA
Matveev V.B., Figurin K.M., Volkova M.I., Chernyaev V.A., Mitin A.V.
Bilateral urothelial carcinoma of the renal pelvis
Gilivanova G.V., Kipriyanov E.A., Karnaukh P.A., Ivakhno K.Y., Peretrukhin A.A., Zolotykh M.A., Beydzhanov M.T., Rostovtsev D.M.
New treatment options for advanced urothelial cancer: a combination of atesolizumab with chemotherapy
Alekseev B.Y., Shevchuk I.M.
KIM-1 as a potential serological/urinological tumor-associated marker of renal cell carcinoma and chemotherapy nephrotoxicity
Solokhina M.P., Sergeeva N.S., Marshutina N.V., Alentov I.I., Kanukoev K.Y., Nyushko K.M., Alekseev B.Y., Kaprin A.D.
Prospects of 2nd line chemotherapy personalization in patients with metastatic castration-resistant prostate cancer
Alekseev B.Y., Nyushko K.M.
Results of a unicenter randomized study of the safety and efficiency of docetaxel chemotherapy before radical prostatectomy in patients with intermediate- and high-risk prostate cancer: An 11.4-year follow-up
Nosov A.K., Petrov S.B., Reva S.A., Mamizhev E.M., Novikov R.V., Veliev E.I., Moiseenko V.M.
COMPARATIVE ANALYSIS OF THE THERAPEUTIC EFFICACY OF PROSPIDINE AND CISPLATIN IN NEOADJUVANT INTRAVESICAL CHEMOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
Shabunina T.I., Selivanov S.P., Udud E.V., Kladiev A.A., Barysheva E.V., Kovalik T.A., Isaeva S.N.
1 - 52 of 52 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"